Cliff Asness’s Sana Biotechnology SANA Stock Holding History

Cliff Asness’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.36M	Sell	963,147 -161,132	-14%	-$519K	﹤0.01%	2269
2026 Q1	$3.24M	Sell	1,124,279 -10,045	-0.9%	-$39.6K	﹤0.01%	2038
2025 Q4	$4.62M	Sell	1,134,324 -47,458	-4%	-$213K	﹤0.01%	1614
2025 Q3	$4.2M	Sell	1,181,782 -174,581	-13%	-$631K	﹤0.01%	1557
2025 Q2	$3.7M	Buy	1,356,363 +783,217	+137%	+$1.62M	﹤0.01%	1447
2025 Q1	$963K	Buy	573,146 +190,483	+50%	+$532K	﹤0.01%	2037
2024 Q4	$624K	Buy	382,663 +311,255	+436%	+$928K	﹤0.01%	2141
2024 Q3	$297K	Buy	+71,408	New	+$375K	﹤0.01%	2400
2024 Q2	–	Sell	-155,792	Closed	-$1.56M	–	2668
2024 Q1	$1.56M	Buy	155,792 +131,475	+541%	+$985K	﹤0.01%	1511
2023 Q4	$99.2K	Buy	+24,317	New	+$89.6K	﹤0.01%	2279

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Cliff Asness's SANA Position: Q2 2026 in Review

Cliff Asness reduced its Sana Biotechnology (SANA) stake by 14% in Q2 2026, selling an estimated $519K and leaving 963,147 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Cliff Asness first reported a position in SANA in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.62M in Q4 2025. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Cliff Asness held 963,147 shares of Sana Biotechnology worth $3.36M as of Q2 2026.
Cliff Asness sold 161,132 Sana Biotechnology shares in Q2 2026, an estimated $519K.
Sana Biotechnology made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2269 holding.
Cliff Asness first reported a position in Sana Biotechnology in Q4 2023 and has held it in 10 quarters since.
Cliff Asness's Sana Biotechnology position peaked at $4.62M in Q4 2025.
208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.